The primary goal of this study is to quantify the benefit of adding artesunate to amodiaquine in treating patients with uncomplicated P. falciparum malaria, in a low transmission area in Colombia. The benefit will be assessed in terms of: * Efficacy * Tolerability * Time of fever clearance * Time of parasite clearance * Proportion of gametocyte carriers
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
360
Hospital Ismael Roldan and Centro de Salud San Vicente
Quibdó, Departamento del Chocó, Colombia
treatment failures
adverse events
gametocyte carriage
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.